Sunteți pe pagina 1din 5

Pathcare Labs Pvt. Ltd.

Regional Laboratory - Plot No.526, Phase-5, Udyog


Vihar, Gurugram-122016
Ph:- 0113043182801130431831

Patient Name : Mr. SURESH GUPTA Reg. No. : 00401803250010


Age and Sex : 60 Yrs / Male PCC Code : PCL-DL-126B
Referring Doctor : NA Sample Drawn Date : 25-Mar-2018 09:08 AM
Referring Customer : PO2632221749-587 Registration Date : 25-Mar-2018 04:03 PM
Vial ID : G1747101 Report Date : 25-Mar-2018 05:04 PM
Sample Type : WB-EDTA
Client Address : New Delhi,

HEMATOLOGY
BODY PROFILE - 1 MG
Test Name Obtained Value Units Bio. Ref. Intervals(Age/Gender specific) Method

Complete Blood Count (CBC)


Haemoglobin 13.3 g/dL 13-17 Cynmeth Method
Total WBC Count 7200 10^6/L 4000-10000 Cell Impedence -
Cell Counter
Neutrophils 62 % 40-80
Lymphocytes 32 % 20-40
Monocytes 04 % 2-10
Eosinophils 02 % 1-6
Basophils 00 % <1-2
Others 0 % 00
RBC Count 5.44 10^12/L 4.5-5.5 Cell Impedence
Haematocrit (HCT) 41.1 % 40-50
MCV 75.6 fl 81-101 Cell counter-
Calculatd
MCH 24.4 pg 27-32 Cell counter-
Calculatd
MCHC 32.3 g/dl 32.5-34.5 Cell counter-
Calculatd
RDW-CV 15.2 % 11.6-14.0
Platelet Count 279 10^9/L 150-410 Cell Impedence
Remarks -
-

Page 1 of 5

Note: If the test results are alarming or unexpected,Client is advised to contact the laboratory immediately for possible remedial action.
Pathcare Labs Pvt. Ltd.
Regional Laboratory - Plot No.526, Phase-5, Udyog
Vihar, Gurugram-122016
Ph:- 0113043182801130431831

Patient Name : Mr. SURESH GUPTA Reg. No. : 00401803250010


Age and Sex : 60 Yrs / Male PCC Code : PCL-DL-126B
Referring Doctor : NA Sample Drawn Date : 25-Mar-2018 09:08 AM
Referring Customer : PO2632221749-587 Registration Date : 25-Mar-2018 04:03 PM
Vial ID : G1747099 Report Date : 25-Mar-2018 06:16 PM
Sample Type : Urine
Client Address : New Delhi,

CLINICAL PATHOLOGY
BODY PROFILE - 1 MG
Test Name Obtained Value Units Bio. Ref. Intervals(Age/Gender specific) Method

Complete Urine Analysis (CUE)


PHYSICAL EXAMINATION
Colour Pale Yellow - Straw to light amber
Appearence Clear - Clear
CHEMICAL EXAMINATION
Glucose Absent - Negative
Protein Absent - Negative
Bilirubin (Bile) Negative - Negative
Ketone Bodies Absent - Negative
Specific gravity 1.025 - 1.001 - 1.035
Blood Negative - Negative
Reaction (pH) 6.0 - 4.6 - 8.0
Nitrites Negative - Nagative
Leukocyte Esterase Negative - Negative
MICROSCOPIC EXAMINATION
PUS(WBC) Cells 2-4 /hpf 00-05
Red Blood Cells Absent /hpf Nil
U.Epithelial Cells 2-3 /hpf 00-05
Casts Absent - Occasional Hyaline cast
Crystals Absent - Absent
Others - -
-

Page 2 of 5

Note: If the test results are alarming or unexpected,Client is advised to contact the laboratory immediately for possible remedial action.
Pathcare Labs Pvt. Ltd.
Regional Laboratory - Plot No.526, Phase-5, Udyog
Vihar, Gurugram-122016
Ph:- 0113043182801130431831

Patient Name : Mr. SURESH GUPTA Reg. No. : 00401803250010


Age and Sex : 60 Yrs / Male PCC Code : PCL-DL-126B
Referring Doctor : NA Sample Drawn Date : 25-Mar-2018 09:08 AM
Referring Customer : PO2632221749-587 Registration Date : 25-Mar-2018 04:03 PM
Vial ID : G1747100, G1747102, G1747103, Report Date : 25-Mar-2018 05:45 PM
Sample Type : Serum, Plasma-Sodium Fluoride
Client Address : New Delhi,

CLINICAL BIOCHEMISTRY
BODY PROFILE - 1 MG
Test Name Obtained Value Units Bio. Ref. Intervals(Age/Gender specific) Method

*Calcium 9.9 mg/dl 8.5 - 10.1 O-


cresolphthalein
complexon
(OCPC)
*Glucose-Blood-Fasting 156.0 mg/dL 60 - 110
*Glucose - PLBS 217.00 mg/dL 90 - 140
*Glycosylated 12.4 % < 6 : Non Diabetic Capillary
Hemoglobin(GHb/HbA1c) 6-7 : Good Control Electrophoresis
7-8 : Weak Control /HPLC
> 8 : Poor Control
*Glycosylated Hemoglobin 112.02 mmol/mol Calculated
*Mean Blood Glucose 309.18 mg/dL 90 - 120 : Excellent Control Calculated
121 - 150 : Good Control
151 - 180 : Average Control
181 - 210 : Action Suggested
>211 :Panic Value
Comments:

HbA1c is an indicator of glycemic control.HbA1c represents average glycemia over the past six to eight weeks.Glycation of hemoglobin occurs over the entire 120 day life span of the red blood cell, but with in this 120
days. Clinical studies suggest that a patient in stable control will have 50% of their HbA1c formed in the month before sampling, 25% in the month before that, and the remaining 25% in months two to four.
Mean Plasma Glucose mg/dl = 28.7 X A1C – 46.7   Correlation between HbA1c and Mean Plasma Glucose (MPG) is not "perfect" but rather only this means that to predict or estimate average glucose from Hb-A1c or
vice-versa is not "perfect" but gives a good working ballpark estimate.
Afternoon and evening results correlate more closely to HbA1c than morning results, perhaps because morning fasting glucose levels vary much more than daytime glucose levels, which are easier to predict and
control. As per IFCC recommendations 2007, HbA1c being reported as above maintaining traceability to both IFCC (mmol/mol) & NGSP (%) units.

Iron Deficiency Profile-I


Ferritin 67.8 ng/mL 22 - 322 CLIA
Iron Binding Capacity - Total (TIBC) 334 µg/dL 250 - 450 Ferene
Iron 38 µg/dL 65-175 Ferene
Transferrin 233.57 mg/dL 176 - 280 Calculated
% Iron Saturation 11.38 % 20 - 50 Calculated

Page 3 of 5

Note: If the test results are alarming or unexpected,Client is advised to contact the laboratory immediately for possible remedial action.
Pathcare Labs Pvt. Ltd.
Regional Laboratory - Plot No.526, Phase-5, Udyog
Vihar, Gurugram-122016
Ph:- 0113043182801130431831

Patient Name : Mr. SURESH GUPTA Reg. No. : 00401803250010


Age and Sex : 60 Yrs / Male PCC Code : PCL-DL-126B
Referring Doctor : NA Sample Drawn Date : 25-Mar-2018 09:08 AM
Referring Customer : PO2632221749-587 Registration Date : 25-Mar-2018 04:03 PM
Vial ID : G1747100, G1747102, G1747103, Report Date : 25-Mar-2018 05:45 PM
Sample Type : Serum, Plasma-Sodium Fluoride
Client Address : New Delhi,

CLINICAL BIOCHEMISTRY
BODY PROFILE - 1 MG
Test Name Obtained Value Units Bio. Ref. Intervals(Age/Gender specific) Method

Lipid Profile
Cholesterol Total 178 mg / dL < 200 : Normal CHOD PAP
Cholesterol HDL 36 mg / dL 35 - 60 Direct
Homogenous
Cholesterol - LDL 120 mg/dl 70 - 180 Calculated
Cholesterol VLDL 22 mg/dL 7-40 Calculated
Triglycerides 110 mg/dL 0 - 150 GPO -POD
Cholesterol Total/Cholesterol HDL Ratio 4.94 0 - 4.0 Calculated
Cholesterol LDL/Cholesterol HDL 3.33 0 - 3.5 Calculated
Liver Function Test (LFT)
Bilirubin Total 0.36 mg/dL 0.2-1.2 Diazotization
Bilirubin Direct 0.01 mg/dL 0 - 0.2 Diazotization
Bilurubin Indirect 0.35 mg/dL 0.2 - 1.0 Calculated
Alkaline Phosphatase (ALP) 73 U/L 50-136 PNPP- AMP
Buffer
Aspartate Aminotransferase (SGOT) 17 U/L 15-37 UV With P5P
Alanine Transaminase (ALT/SGPT) 32 U/L 16-63 UV with P5P
Gamma Glutamyl Transferase (GGT) 46 U/L 15 - 85 IFCC -GCNA
Protein Total 7.2 g/dL 6.4 - 8.2 Biuret
Albumin 3.8 g/dL 2.9-4.5 Bromocresol
Purple
Globulin 3.4 g/dl 2.5 - 3.8 Calculated
Albumin / Globulin Ratio 1.12 1.0 - 2.1 Calculated
Kidney Function Test (KFT) - I
Creatinine 1.26 mg/dL 0.70-1.30 Jaffe Kinetic
Urea 49.9 mg/dL 10 - 50 Urease GLDH
Uric Acid 6.1 mg/dL 3.5 - 7.2 Urease PAP
Sodium (Na) 139.7 mmol/L 135 - 145 ISE Direct
Potassium (K) 4.01 mmol/L 3.8 - 5.2 ISE Direct
Chloride(CL) 99.5 mmol/L 98 - 108 ISE Direct

Page 4 of 5

Note: If the test results are alarming or unexpected,Client is advised to contact the laboratory immediately for possible remedial action.
Pathcare Labs Pvt. Ltd.
Regional Laboratory - Plot No.526, Phase-5, Udyog
Vihar, Gurugram-122016
Ph:- 0113043182801130431831

Patient Name : Mr. SURESH GUPTA Reg. No. : 00401803250010


Age and Sex : 60 Yrs / Male PCC Code : PCL-DL-126B
Referring Doctor : NA Sample Drawn Date : 25-Mar-2018 09:08 AM
Referring Customer : PO2632221749-587 Registration Date : 25-Mar-2018 04:03 PM
Vial ID : G1747100, G1747102, G1747103, Report Date : 25-Mar-2018 05:45 PM
Sample Type : Serum, Plasma-Sodium Fluoride
Client Address : New Delhi,

CLINICAL BIOCHEMISTRY
BODY PROFILE - 1 MG
Test Name Obtained Value Units Bio. Ref. Intervals(Age/Gender specific) Method

Thyroid Profile I
Tri-Iodothyronine Total (TT3) 78.9 ng/dL 40 - 181 CLIA
Thyroxine - Total (TT4) 6.7 µg/dL 4.6 - 10.5 CLIA
Thyroid Stimulating Hormone (TSH) 3.74 µIU/mL 0.5-8.9 CLIA

Interpretation:

TT3 TT4 TSH

Adolescents Pediatric Pregnancy


( As per American Thyroid Association)
16 - 20yrs 80 - 210 ng/dL CordBlood        7.4 - 13.1 µg/dL           1 Trimester        0.10 - 2.50 µlU/mL
Pregnancy Birth - 3 Days   11.8 - 22.6 µg/dL          2 Trimester        0.20 -  3.00 µIU/mL
1 Trimester 81 - 190 ng/dL 4 Days - 5 Yrs  7.2 - 16.6 µg/dL            3 Trimester        0.30 - 3.00 µlU/mL
2 & 3 Trimister 100 - 260 ng/dL 5 - 15 Yrs         5.6 - 13.3 µg/dL                    Pediatric
Pediatric Cord Blood  2.3 - 13.2 µlU/mL
Cord Blood 5 - 141 ng/dL Birth - 4 Days  1.0 - 39.0 µlU/mL
Birth - 3 Days 100 - 700 ng/dL 2 - 20 Weeks  1.7 - 9.1 µlU/mL
4 Days - 1 Month 160 - 240 ng/dL 20 Wk - 18 Yrs  0.3 - 5.0 µlU/mL
1 Month - 1 Yr 105 - 245 ng/dL Premature infant  0.5 - 29.0 µlU/mL
1 - 5 Yrs 105- 269 ng/dL
5 - 15Yrs 82 - 241 ng/dL

- Assay results should be interpreted in context to the clinical condition and associated results of other investigations.
- Previous treatment with corticosteroid therapy may result in lower TSH levels while thyroid hormone levels are normal
- Results are invalidated if the client has undergone a radionuclide scan within 7-14 days before the test.
- Abnormal thyroid test findings often found in critically ill clients should be repeated after the critical nature of the condition is resolved.
- The production, circulation, and disposal of thyroid hormone are altered throughout the stages of pregnancy.

Correlate Clinically.

Result rechecked and verified for abnormal cases

*** End Of Report ***

Page 5 of 5

Note: If the test results are alarming or unexpected,Client is advised to contact the laboratory immediately for possible remedial action.

S-ar putea să vă placă și